Complement Mediated Signaling on Pulmonary CD103+ Dendritic Cells Is Critical for Their Migratory Function in Response to Influenza Infection

PLoS Pathogens

Volumn 9, Issue 1, 2013, Pages

  Kandasamy, Matheswaran ^a   Ying, Poon C ^a   Ho, Adrian W S ^b   Sumatoh, Hermi R ^a   Schlitzer, Andreas ^b   Hughes, Timothy R ^c   Kemeny, David M ^d   Morgan, B Paul ^c   Ginhoux, Florent ^b   Sivasankar, Baalasubramanian ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; CD103 ANTIGEN; CD11B ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; DIPHTHERIA TOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IN VIVO STUDY; INFLUENZA; MALE; MATURATION; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

ANIMALS; ANTIGENS, CD; ANTIGENS, VIRAL; CELL MOVEMENT; COMPLEMENT C3; COMPLEMENT C5A; DENDRITIC CELLS; INTEGRIN ALPHA CHAINS; LUNG; MICE; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION; SURVIVAL RATE; T-LYMPHOCYTES; VIRAL LOAD; VIRUSES;

EID: 84875080678     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003115     Document Type: Article

References (56)

1. Brown LE, Kelso A, (2009) Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol Cell Biol 87: 300-308.
2. Lee LY, Ha do LA, Simmons C, de Jong MD, Chau NV, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118: 3478-3490.
3. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL, (2010) Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol 84: 9217-9226.
4. Legge KL, Braciale TJ, (2003) Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18: 265-277.
5. Belz GT, Smith CM, Kleinert L, Reading P, Brooks A, et al. (2004) Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci U S A 101: 8670-8675.
6. Steinman RM, (2007) Dendritic cells: understanding immunogenicity. Eur J Immunol 37 Suppl 1: S53-60.
7. Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, et al. (2009) The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 206: 3115-3130.
8. del Rio ML, Rodriguez-Barbosa JI, Kremmer E, Forster R, (2007) CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J Immunol 178: 6861-6866.
9. Sung SS, Fu SM, Rose CE Jr, Gaskin F, Ju ST, et al. (2006) A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 176: 2161-2172.
10. GeurtsvanKessel CH, Willart MA, van Rijt LS, Muskens F, Kool M, et al. (2008) Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med 205: 1621-1634.
11. Pepys MB, (1974) Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med 140: 126-145.
12. Carroll MC, (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5: 981-986.
13. Kimberley FC, Sivasankar B, Paul Morgan B, (2007) Alternative roles for CD59. Mol Immunol 44: 73-81.
14. Ricklin D, Hajishengallis G, Yang K, Lambris JD, (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
15. Suresh M, Molina H, Salvato MS, Mastellos D, Lambris JD, et al. (2003) Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol 170: 788-794.
16. Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF, (2002) Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 8: 373-378.
17. Mehlhop E, Diamond MS, (2006) Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med 203: 1371-1381.
18. Vieyra M, Leisman S, Raedler H, Kwan WH, Yang M, et al. (2011) Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection. Am J Pathol 179: 766-774.
19. Strainic MG, Liu J, Huang D, An F, Lalli PN, et al. (2008) Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28: 425-435.
20. Li K, Fazekasova H, Wang N, Peng Q, Sacks SH, et al. (2012) Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 217: 65-73.
21. Allenspach EJ, Lemos MP, Porrett PM, Turka LA, Laufer TM, (2008) Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity 29: 795-806.
22. O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S, (2011) A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One 6: e17377.
23. Ohta R, Torii Y, Imai M, Kimura H, Okada N, et al. (2011) Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol Immunol 55: 191-198.
24. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, et al. (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182: 7353-7363.
25. Ho AW, Prabhu N, Betts RJ, Ge MQ, Dai X, et al. (2011) Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J Immunol 187: 6011-6021.
26. Moltedo B, Li W, Yount JS, Moran TM, (2011) Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog 7: e1002345.
27. Ballesteros-Tato A, Leon B, Lund FE, Randall TD, (2010) Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol 11: 216-224.
28. Banki Z, Posch W, Ejaz A, Oberhauser V, Willey S, et al. (2010) Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs. PLoS Pathog 6: e1000891.
29. Grayson MH, Ramos MS, Rohlfing MM, Kitchens R, Wang HD, et al. (2007) Controls for lung dendritic cell maturation and migration during respiratory viral infection. J Immunol 179: 1438-1448.
30. Heer AK, Harris NL, Kopf M, Marsland BJ, (2008) CD4+ and CD8+ T cells exhibit differential requirements for CCR7-mediated antigen transport during influenza infection. J Immunol 181: 6984-6994.
31. Shortman K, Naik SH, (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7: 19-30.
32. Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, et al. (2007) Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110: 228-236.
33. Kim AH, Dimitriou ID, Holland MC, Mastellos D, Mueller YM, et al. (2004) Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol 173: 2524-2529.
34. Kohl J, Wills-Karp M, (2007) Complement regulates inhalation tolerance at the dendritic cell/T cell interface. Mol Immunol 44: 44-56.
35. Bouchon A, Hernandez-Munain C, Cella M, Colonna M, (2001) A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 194: 1111-1122.
36. Randolph GJ, Ochando J, Partida-Sanchez S, (2008) Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 26: 293-316.
37. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL, (2006) The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 176: 5153-5159.
38. Eisenbarth SC, Williams A, Colegio OR, Meng H, Strowig T, et al. (2012) NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484: 510-513.
39. Peng Q, Li K, Wang N, Li Q, Asgari E, et al. (2009) Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol 183: 6058-6068.
40. Zhou W, Patel H, Li K, Peng Q, Villiers MB, et al. (2006) Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107: 2461-2469.
41. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
42. Naik SH, Metcalf D, van Nieuwenhuijze A, Wicks I, Wu L, et al. (2006) Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7: 663-671.
43. Kim TS, Braciale TJ, (2009) Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 4: e4204.
44. Nakayama Y, Kim SI, Kim EH, Lambris JD, Sandor M, et al. (2009) C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection. J Immunol 183: 2921-2931.
45. Topham DJ, Tripp RA, Doherty PC, (1997) CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 159: 5197-5200.
46. Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, et al. (2011) Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 17: 195-199.
47. Reis ES, Falcao DA, Isaac L, (2006) Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 63: 155-168.
48. Garred P, Larsen F, Madsen HO, Koch C, (2003) Mannose-binding lectin deficiency-revisited. Mol Immunol 40: 73-84.
49. Eisen DP, Minchinton RM, (2003) Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37: 1496-1505.
50. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
51. Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana A, et al. (2007) Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 204: 1249-1256.
52. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38: 458-462.
53. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
54. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, et al. (2007) Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 204: 2277-2283.
55. Heurich M, Martinez-Barricarte R, Francis NJ, Roberts DL, Rodriguez de Cordoba S, et al. (2011) Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc Natl Acad Sci U S A 108: 8761-8766.
56. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, et al. (2009) Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 17: 100-104.